Skip to main content
OpenTrials
Completed

NCT Number: NCT07675278

Comparing Two Agents Used to Stop Bleeding During Tonsil Removal Surgery: Adrenaline Versus Hydrogen Peroxide

The goal of this quasi-experimental study is to compare the effectiveness of topical adrenaline and 3% hydrogen peroxide for controlling bleeding (hemostasis) during tonsil removal surgery in patients aged 5 to 18 years. The main questions it aims to answer are: 1. Which substance leads to faster bleeding control during surgery? 2. Which substance results in less total blood loss during surgery? Researchers compared the adrenaline group to the hydrogen peroxide group to see if one agent was more effective at managing bleeding than the other. Participants underwent a tonsillectomy where surgeons applied either gauze soaked in adrenaline (1:100,000 solution) or gauze soaked in 3% hydrogen peroxide to the tonsil area to stop bleeding.

Completed

Looking for future studies?

Notify Me

Key information

Age range

5 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rawalpindi Teaching Hospital

Rawalpindi, Punjab Province, 46000, Pakistan

About this study

This study was conducted as a quasi-experimental comparative analysis to evaluate the efficacy of two common topical hemostatic agents, adrenaline (1:100,000 solution) and 3% hydrogen peroxide, during elective tonsillectomy. All procedures were performed in the Department of Otorhinolaryngology at Rawalpindi Teaching Hospital. Surgeons of a consistent training level performed all tonsillectomies using the dissection technique to minimize inter-operator variability. The allocation of patients to either the adrenaline or hydrogen peroxide group was determined by the surgical date (even-numbered dates for adrenaline; odd-numbered dates for hydrogen peroxide). To maintain measurement rigor, blood loss was assessed by personnel blinded to the group assignment, utilizing both gravimetric and volumetric methods. The dry weight of standard surgical gauze was recorded preoperatively and compared against the weight of blood-soaked gauze post-use to estimate blood volume, utilizing a blood specific gravity of 1.055 g/mL. Additionally, suction canister volumes were measured, with adjustments made for any irrigation fluid used during the procedure. Intraoperative hemostasis was defined as the complete cessation of bleeding from the tonsillar fossa without the requirement for further hemostatic intervention. Time to achieve hemostasis was recorded by the operating team and categorized into four intervals: <1 minute, 1-3 minutes, 3-5 minutes, and >5 minutes. Total intraoperative blood loss was calculated as the aggregate of the gravimetric (gauze) and volumetric (suction) assessments and was ordinally classified as mild (16-75 mL), moderate (76-275 mL), or severe (>275 mL). Statistical analysis was performed using IBM SPSS Statistics version 25.0, employing the Mann-Whitney U test for non-normally distributed time-to-hemostasis data and the Chi-square test for ordinal blood loss categories.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged 5-18 years.
  • Scheduled for elective tonsillectomy.
  • Diagnosis of chronic or recurrent tonsillitis.
  • Normal coagulation profile.
  • Medically fit for general anesthesia.
  • Provided informed consent (from participant, or parent/legal guardian for pediatric participants).

Exclusion criteria

  • Patients with a coagulation or bleeding disorder.
  • Patients taking blood-thinning medications (e.g., aspirin or other antiplatelet agents).
  • Presence of an acute tonsillar infection at the time of surgery.
  • Known reaction or allergy to adrenaline or hydrogen peroxide.
  • Known or suspected tonsillar malignancy.
  • Concurrent adenoid hypertrophy requiring adenoidectomy.

Treatment and study plan

Adrenaline

Drug

Topical application of 1:100,000 adrenaline solution.

Other names: Epinephrine

Hydrogen Peroxide

Drug

Topical application of 3% hydrogen peroxide solution.

Other names: H2O2

Primary outcomes

  1. Severity of intraoperative blood loss during tonsillectomy as classified by combined gravimetric and volumetric assessment.

    Time frame: Measured during the intraoperative period, specifically from the time of hemostatic agent application until the completion of the tonsillectomy procedure.

    Total volume of blood lost during the surgical procedure, determined by the sum of blood volume calculated from the gravimetric method (pre- and post-operative weight of surgical gauze) and the volumetric method (suction canister volume). Results are categorized ordinally as: Mild (16-75 mL), Moderate (76-275 mL), or Severe (>275 mL).

  2. Time to achieve intraoperative hemostasis during tonsillectomy as measured in minutes.

    Time frame: Measured during the intraoperative period, specifically from the time of hemostatic agent application until the completion of the tonsillectomy procedure.

    Time from the application of the hemostatic agent until the complete cessation of bleeding from the tonsillar fossa, as recorded by the surgical team. Time is recorded in categorical intervals: <1 minute, 1-3 minutes, 3-5 minutes, and >5 minutes.

Sponsors and collaborators

Lead sponsor

Rawalpindi Medical College

Other

Registry information

Official study title

Efficacy of Hydrogen Peroxide Versus Adrenaline for Intraoperative Hemostasis During Tonsillectomy. A Quasi-Experimental Study

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jun 30, 2026
Registry last updated
Jun 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.